Who is sponsoring NCT06760377?

NCT06760377 is sponsored by Universidad Complutense de Madrid.

What drugs are being tested in NCT06760377?

Interventions in NCT06760377: Dietary supplement Group.

What condition does NCT06760377 study?

NCT06760377 studies Intestinal Permeability, Leaky Gut Syndrome, Zonulin.

Is NCT06760377 still recruiting?

NCT06760377 is currently not yet recruiting. Last updated 6 January 2025.

Last reviewed 2025-01-06 · How we verify

NCT06760377: permeability

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dietary Supplements for Reduction of Intestinal Permeability Levels

Not yet recruiting NA Last updated 6 January 2025

What this trial tests

NA trial testing Dietary supplement Group in Intestinal Permeability in 85 participants. Not yet recruiting.

Timeline

1 February 2025

Primary endpoint
1 April 2025

1 June 2025

Quick facts

Lead sponsor	Universidad Complutense de Madrid
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	85
Start date	1 February 2025
Primary completion	1 April 2025
Estimated completion	1 June 2025
Sites	1 location across Spain

Drugs / interventions tested

Dietary supplement Group

Conditions studied

Intestinal Permeability — all drugs for Intestinal Permeability →
Leaky Gut Syndrome — all drugs for Leaky Gut Syndrome →
Zonulin — all drugs for Zonulin →

Sponsor

Universidad Complutense de Madrid — full company profile →

Who can join

Adults 18 to 65, any sex, with Intestinal Permeability or Leaky Gut Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomised and controlled trial, in which the effect of a dietary supplement is evaluated for reduction of intestinal permeability levels of subjects with high levels of zonulin in feces

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Intestinal Permeability

Currently open trials in the same condition.

NCT04083950 — Induction of Gut Permeability by an Oral Vaccine · EARLY_PHASE1 · active not recruiting

Other Universidad Complutense de Madrid trials

Trials by the same sponsor.

NCT07361848 — Long-Hold Yielding Isometric Exercise for Patellar Tendinopathy in Weightlifting Athletes · NA · not yet recruiting
NCT07273006 — Percutaneous Electrical Nerve Stimulation As Alternative To Nerve Blocks In Anesthesia, Pain Medicine And Rehabilitation · Phase 4 · not yet recruiting
NCT07527351 — ANALYSIS OF THE RELIABILITY AND VALIDITY OF LASER SPECKLE CONTRAST IMAGING · NA · recruiting
NCT07484620 — Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease · NA · not yet recruiting
NCT07485400 — Aerobic Interval vs Continuous Training on Heart Rate-Power Decoupling in Ischemic Heart Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06760377 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Complutense de Madrid
Last refreshed: 6 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06760377.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing